Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy.
Berardi R, Rinaldi S, Santoni M, Newsom-Davis T, Tiberi M, Morgese F, Caramanti M, Savini A, Ferrini C, Torniai M, Fiordoliva I, Bower M, Cascinu S. Berardi R, et al. Among authors: fiordoliva i. Oncotarget. 2016 May 3;7(18):26916-24. doi: 10.18632/oncotarget.8309. Oncotarget. 2016. PMID: 27029035 Free PMC article.
Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis.
Cantini L, Pecci F, Murrone A, Tomasetti M, Copparoni C, Fiordoliva I, Morgese F, Rinaldi S, Mazzanti P, Rubini C, Cimadamore A, Barbisan F, Giampieri R, Scarpelli M, Santarelli L, Berardi R. Cantini L, et al. Among authors: fiordoliva i. Lung Cancer. 2020 Aug;146:318-326. doi: 10.1016/j.lungcan.2020.06.024. Epub 2020 Jun 21. Lung Cancer. 2020. PMID: 32622302
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma.
Berardi R, Caramanti M, Fiordoliva I, Morgese F, Savini A, Rinaldi S, Torniai M, Tiberi M, Ferrini C, Castagnani M, Rovinelli F, Onofri A, Cascinu S. Berardi R, et al. Among authors: fiordoliva i. Support Care Cancer. 2015 Mar;23(3):621-6. doi: 10.1007/s00520-014-2398-6. Epub 2014 Aug 21. Support Care Cancer. 2015. PMID: 25142706
Hyponatremia in cancer patients: Time for a new approach.
Berardi R, Rinaldi S, Caramanti M, Grohè C, Santoni M, Morgese F, Torniai M, Savini A, Fiordoliva I, Cascinu S. Berardi R, et al. Among authors: fiordoliva i. Crit Rev Oncol Hematol. 2016 Jun;102:15-25. doi: 10.1016/j.critrevonc.2016.03.010. Epub 2016 Mar 10. Crit Rev Oncol Hematol. 2016. PMID: 27066939 Review.
Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials.
Berardi R, Santoni M, Rinaldi S, Nunzi E, Smerilli A, Caramanti M, Morgese F, Torniai M, Savini A, Fiordoliva I, Onofri A, Pistelli M, Taccaliti A, Cascinu S. Berardi R, et al. Among authors: fiordoliva i. PLoS One. 2016 May 11;11(5):e0152079. doi: 10.1371/journal.pone.0152079. eCollection 2016. PLoS One. 2016. PMID: 27167519 Free PMC article. Review.
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: A systematic review and meta-analysis.
Cantini L, Merloni F, Rinaldi S, Lenci E, Marcantognini G, Meletani T, Fiordoliva I, Morgese F, Torniai M, Ricci G, Giampieri R, Berardi R. Cantini L, et al. Among authors: fiordoliva i. Crit Rev Oncol Hematol. 2020 Jul;151:102974. doi: 10.1016/j.critrevonc.2020.102974. Epub 2020 May 4. Crit Rev Oncol Hematol. 2020. PMID: 32416348
Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study.
Berardi R, Mocchegiani F, Rinaldi S, Fiordoliva I, Rovinelli F, Caramanti M, Federici A, Burattini M, Morgese F, Torniai M, Marcantognini G, Vivarelli M. Berardi R, et al. Among authors: fiordoliva i. Oncol Ther. 2020 Jun;8(1):115-124. doi: 10.1007/s40487-020-00112-6. Epub 2020 Apr 1. Oncol Ther. 2020. PMID: 32700076 Free PMC article.
18 results